[Hormone therapy and risk for venous thromboembolism in postmenopausal women].

Abstract : Oral estrogens are associated with a two-fold to three-fold increased risk of venous thromboembolism in postmenopausal women. Absolute excess risk is low but higher than for contraceptive pills. Biological data and observational studies suggest that transdermal estrogens are associated with a lower risk for venous thromboembolism than oral estrogens but safety has yet to be proved. Whether addition of progestin plays a significant role is undetermined so far.
Type de document :
Article dans une revue
Revue du Praticien (La), J B Bailliere et Fils, 2005, 55 (4), pp.389-92
Liste complète des métadonnées

http://hal.univ-brest.fr/hal-00722073
Contributeur : Ghislaine Calvez <>
Soumis le : mardi 31 juillet 2012 - 16:21:52
Dernière modification le : mercredi 10 janvier 2018 - 14:42:02

Identifiants

  • HAL Id : hal-00722073, version 1
  • PUBMED : 15828617

Collections

Citation

Karine Lacut, Emmanuel Oger. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].. Revue du Praticien (La), J B Bailliere et Fils, 2005, 55 (4), pp.389-92. 〈hal-00722073〉

Partager

Métriques

Consultations de la notice

41